Selected research
Industry Growth & Trends
Global Diabetes Screening Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Diabetes Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Diabetes Screening is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Diabetes Screening is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diabetes Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Diabetes Screening market include InSphero AG, Abbott Laboratories, American Laboratory Products Company (ALPCO), Beckmann Coulter Inc., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG and PTS Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Diabetes Screening market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Diabetes Screening market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diabetes Screening market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diabetes Screening.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Diabetes Screening market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Diabetes Screening Market by Company
InSphero AG
Abbott Laboratories
American Laboratory Products Company (ALPCO)
Beckmann Coulter Inc.
Bio-Rad Laboratories Inc.
Ortho Clinical Diagnostics Inc.
F. Hoffmann-la Roche Ltd
Siemens AG
PTS Diagnostics
Diabetes Screening Segment by Type
Instrument
Test Suite
Reagents
Diabetes Screening Segment by Application
Hospital
Specialty Clinic
Diagnostic Center
Home Care
Academic Research Institution
Diabetes Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetes Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetes Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetes Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Diabetes Screening companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Instrument
- Test Suite
- Reagents
Applications
- Hospital
- Specialty Clinic
- Diagnostic Center
- Home Care
- Academic Research Institution
Companies covered
- InSphero AG
- Abbott Laboratories
- American Laboratory Products Company (ALPCO)
- Beckmann Coulter Inc.
- Bio-Rad Laboratories Inc.
- Ortho Clinical Diagnostics Inc.
- F. Hoffmann-la Roche Ltd
- Siemens AG
- PTS Diagnostics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Diabetes Screening Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Diabetes Screening Market Size by Region (2021-2032)
- 1.4.1 Global Diabetes Screening Market Size by Region (2021-2026)
- 1.4.2 Global Diabetes Screening Market Size by Region (2027-2032)
- 1.5 Key Regions Diabetes Screening Market Size (2021-2032)
- 1.5.1 North America Diabetes Screening Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Diabetes Screening Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Diabetes Screening Market Size Growth Rate (2021-2032)
- 1.5.4 South America Diabetes Screening Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Diabetes Screening Market Size Growth Rate (2021-2032)
2 Diabetes Screening Market by Type
- 2.1 Type Introduction
- 2.1.1 Instrument
- 2.1.2 Test Suite
- 2.1.3 Reagents
- 2.2 Global Diabetes Screening Market Size by Type
- 2.2.1 Global Diabetes Screening Market Size Overview by Type (2021-2032)
- 2.2.2 Global Diabetes Screening Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Diabetes Screening Market Size Forecasted by Type (2027-2032)
- 2.3 Global Diabetes Screening Market Size by Regions
- 2.3.1 North America Diabetes Screening Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Diabetes Screening Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Diabetes Screening Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Diabetes Screening Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Diabetes Screening Market Size Breakdown by Type (2021-2026)
3 Diabetes Screening Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Specialty Clinic
- 3.1.3 Diagnostic Center
- 3.1.4 Home Care
- 3.1.5 Academic Research Institution
- 3.2 Global Diabetes Screening Market Size by Application
- 3.2.1 Global Diabetes Screening Market Size Overview by Application (2021-2032)
- 3.2.2 Global Diabetes Screening Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Diabetes Screening Market Size Forecasted by Application (2027-2032)
- 3.3 Global Diabetes Screening Market Size by Regions
- 3.3.1 North America Diabetes Screening Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Diabetes Screening Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Diabetes Screening Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Diabetes Screening Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Diabetes Screening Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Diabetes Screening Industry Trends
- 4.2 Diabetes Screening Industry Drivers
- 4.3 Diabetes Screening Industry Opportunities and Challenges
- 4.4 Diabetes Screening Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Diabetes Screening Revenue (2021-2026)
- 5.2 Global Diabetes Screening Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Diabetes Screening Key Company Headquarters & Area Served
- 5.4 Global Diabetes Screening Company, Product Type & Application
- 5.5 Global Diabetes Screening Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Diabetes Screening Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Diabetes Screening Players Market Share by Revenue in 2025
- 5.6.3 2025 Diabetes Screening Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 InSphero AG
- 6.1.1 InSphero AG Company Information
- 6.1.2 InSphero AG Business Overview
- 6.1.3 InSphero AG Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 InSphero AG Diabetes Screening Product Portfolio
- 6.1.5 InSphero AG Recent Developments
- 6.2 Abbott Laboratories
- 6.2.1 Abbott Laboratories Company Information
- 6.2.2 Abbott Laboratories Business Overview
- 6.2.3 Abbott Laboratories Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Abbott Laboratories Diabetes Screening Product Portfolio
- 6.2.5 Abbott Laboratories Recent Developments
- 6.3 American Laboratory Products Company (ALPCO)
- 6.3.1 American Laboratory Products Company (ALPCO) Company Information
- 6.3.2 American Laboratory Products Company (ALPCO) Business Overview
- 6.3.3 American Laboratory Products Company (ALPCO) Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 American Laboratory Products Company (ALPCO) Diabetes Screening Product Portfolio
- 6.3.5 American Laboratory Products Company (ALPCO) Recent Developments
- 6.4 Beckmann Coulter Inc.
- 6.4.1 Beckmann Coulter Inc. Company Information
- 6.4.2 Beckmann Coulter Inc. Business Overview
- 6.4.3 Beckmann Coulter Inc. Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Beckmann Coulter Inc. Diabetes Screening Product Portfolio
- 6.4.5 Beckmann Coulter Inc. Recent Developments
- 6.5 Bio-Rad Laboratories Inc.
- 6.5.1 Bio-Rad Laboratories Inc. Company Information
- 6.5.2 Bio-Rad Laboratories Inc. Business Overview
- 6.5.3 Bio-Rad Laboratories Inc. Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Bio-Rad Laboratories Inc. Diabetes Screening Product Portfolio
- 6.5.5 Bio-Rad Laboratories Inc. Recent Developments
- 6.6 Ortho Clinical Diagnostics Inc.
- 6.6.1 Ortho Clinical Diagnostics Inc. Company Information
- 6.6.2 Ortho Clinical Diagnostics Inc. Business Overview
- 6.6.3 Ortho Clinical Diagnostics Inc. Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Ortho Clinical Diagnostics Inc. Diabetes Screening Product Portfolio
- 6.6.5 Ortho Clinical Diagnostics Inc. Recent Developments
- 6.7 F. Hoffmann-la Roche Ltd
- 6.7.1 F. Hoffmann-la Roche Ltd Company Information
- 6.7.2 F. Hoffmann-la Roche Ltd Business Overview
- 6.7.3 F. Hoffmann-la Roche Ltd Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 F. Hoffmann-la Roche Ltd Diabetes Screening Product Portfolio
- 6.7.5 F. Hoffmann-la Roche Ltd Recent Developments
- 6.8 Siemens AG
- 6.8.1 Siemens AG Company Information
- 6.8.2 Siemens AG Business Overview
- 6.8.3 Siemens AG Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Siemens AG Diabetes Screening Product Portfolio
- 6.8.5 Siemens AG Recent Developments
- 6.9 PTS Diagnostics
- 6.9.1 PTS Diagnostics Company Information
- 6.9.2 PTS Diagnostics Business Overview
- 6.9.3 PTS Diagnostics Diabetes Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 PTS Diagnostics Diabetes Screening Product Portfolio
- 6.9.5 PTS Diagnostics Recent Developments
7 North America
- 7.1 North America Diabetes Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Diabetes Screening Market Size by Country (2021-2026)
- 7.3 North America Diabetes Screening Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Diabetes Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Diabetes Screening Market Size by Country (2021-2026)
- 8.3 Europe Diabetes Screening Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Diabetes Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Diabetes Screening Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Diabetes Screening Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Diabetes Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Diabetes Screening Market Size by Country (2021-2026)
- 10.3 South America Diabetes Screening Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Diabetes Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Diabetes Screening Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Diabetes Screening Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst